David A. Siegel Health Catalyst, Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 46,000 shares of HCAT stock, worth $357,420. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,000
Previous 170,500
73.02%
Holding current value
$357,420
Previous $1.28 Million
77.16%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding HCAT
# of Institutions
165Shares Held
50.2MCall Options Held
2.51MPut Options Held
1.8K-
Black Rock Inc. New York, NY5.43MShares$42.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.53MShares$35.2 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN3.96MShares$30.7 Million2.3% of portfolio
-
Impax Asset Management Group PLC2.55MShares$19.8 Million0.09% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.41MShares$18.8 Million0.01% of portfolio
About Health Catalyst, Inc.
- Ticker HCAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 54,723,400
- Market Cap $425M
- Description
- Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...